Japan Intellectual Property Rights: ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND TO BCMA AND CD3, AND USES THEREOF

Japan, Sept. 7 -- JANSSEN BIOTECH INC has got intellectual property rights for 'ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND TO BCMA AND CD3, AND USES THEREOF.' Other related details are as follows:

Application Number: JP,2024-184386

Category (FI): A61P37/04,A61K39/395@T,A61K45/00,A61P35/00,A61P43/00,121,C07K16/28,C07K16/46,C12N15/13,C12N15/62@Z,C12N1/15,C12N1/19,C12N1/21,C12N5/10,C12N5/16,C12P21/08,C12P21/02@C,A61K31/417,A61K31/65,A61K31/7068,A61K38/20,A61K39/395@N

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Oct. 18, 2024

Publication Date: Jan. 28, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.